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Chemical contaminants are ubiquitous in the
world’s oceans. Specific health effects and overt
disease in fish have been linked to high concen-
trations of contaminants in some coastal regions
of North America (e.g., Murchelano and Wolke
1991; Myers et al. 1990). Atmospheric pro-
cesses distribute many of these same contami-
nants to the polar regions (MacDonald et al.
2000), where they accumulate in the fatty tissue
of top predators. In the Arctic, prominent
contaminants fall into five broad categories:
chlorinated industrial compounds including
polychlorinated biphenyls (PCBs), organic pes-
ticides, polycyclic aromatic hydrocarbons
(PAHs), metals, and radionuclides (MacDonald
et al. 2000). Persistent contaminants that
accumulate in the lipid-rich blubber of whales
include PCBs, DDT (dichlorodiphenyl-
trichloroethane), and other chlorinated pesti-
cides. Concentrations of these contaminants in
Arctic ecosystems have declined somewhat over
the past 20 years, yet they persist in marine
mammal species, including the beluga (Muir
et al. 1999). Although cetaceans in the Arctic
have contaminant concentrations that are at
least 10 times lower than the most highly conta-
minated cetaceans from other locations
(Norstrom and Muir 1994), Arctic animals may
yet be at risk for adverse health effects.
We obtained multiple internal organ tissue
samples from beluga whales that stranded dead
along the St. Lawrence estuary and during sub-
sistence hunts in the Mackenzie Delta and
Hudson Bay. The St. Lawrence beluga popu-
lation was designated endangered in 1980
(Seargent 1986), a status continued under the
Species at Risk Act in Canada (2002); thus,
stranded animals represent the only means to
obtain tissues for scientific study from this
location. The Mackenzie Delta and Hudson
Bay sites harbor two separate Arctic popula-
tions of beluga, both of which have levels of
PCB and PAH contaminants an order of mag-
nitude lower than those at the St. Lawrence
estuary site. These populations, including the
two Arctic populations, are geographically sep-
arated and represent separate stocks of this
species. Beluga are located in offshore waters
during winter months and in coastal regions
during summer. They have a complex diet
including species of fish and crustaceans,
which is their primary route of exposure to
environmental contaminants.
Among marine mammals, odontocetes
(toothed whales), including beluga, may be
at the greatest risk of contaminant effects
because these animals are top predators that
accumulate contaminants to a higher degree
than do mysticetes (baleen whales) (O’Shea
and Brownell 1994). Concentrations of PCBs
as high as 300 µg/g (lipid weight basis) have
been recorded in odontocete blubber (Ross
et al. 2000). Planar halogenated aromatic
hydrocarbons (PHAHs), the dioxin-like cont-
aminants that include non-ortho and mono-
ortho substituted PCBs, are of special concern
because even at low doses they can affect
development of the immune, nervous, and
reproductive systems in animal models
(Birnbaum and Tuomisto 2000).
Assessing health effects of contaminants in
cetaceans is difficult because experimental expo-
sures are precluded and fresh tissues are rarely
available. Molecular changes associated with
exposure to selected compounds can suggest
whether systemic effects are likely. Cytochrome
P450 1A (CYP1A) induction is elicited by
PAHs and PHAHs via binding to the aryl
hydrocarbon receptor (AHR) (Whitlock 1999).
The mammalian CYP1A gene subfamily con-
tains two members: CYP1A1 and CYP1A2.
Typically in mammals, CYP1A2 expression is
limited to liver, whereas CYP1A1 is more
strongly inducible in extrahepatic organs as
well as liver. CYP1A1 induction has been cor-
related to higher-order toxic effects, including
thymic atrophy, weight loss, and lethal toxicity
induced by PCB, polychlorinated dibenzo-
dioxin, and polychlorinated dibenzofuran
exposure in rodents (Safe 1987). Thus, sys-
temic CYP1A1 expression can indicate a risk
for toxic effects.
In an earlier study, CYP1A1 levels in liver
of Arctic beluga were strongly correlated with
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Cytochrome P450 1A1 (CYP1A1) is induced by exposure to polycyclic aromatic hydrocarbons
(PAHs) and planar halogenated aromatic hydrocarbons (PHAHs) such as non-ortho polychlori-
nated biphenyls (PCBs). In this study, we examined CYP1A1 protein expression immunohisto-
chemically in multiple organs of beluga whales from two locations in the Arctic and from the St.
Lawrence estuary. These beluga populations have some of the lowest (Arctic sites) and highest (St.
Lawrence estuary) concentrations of PCBs in blubber of all cetaceans. Samples from these popula-
tions might be expected to have different contaminant-induced responses, reflecting their different
exposure histories. The pattern and extent of CYP1A1 staining in whales from all three locations
were similar to those seen in animal models in which CYP1A has been highly induced, indicating
a high-level expression in these whales. CYP1A1 induction has been related to toxic effects of
PHAHs or PAHs in some species. In St. Lawrence beluga, the high level of CYP1A1 expression
coupled with high levels of contaminants (including CYP1A1 substrates, e.g., PAH procarcino-
gens potentially activated by CYP1A1) indicates that CYP1A1 could be involved in the develop-
ment of neoplastic lesions seen in the St. Lawrence beluga population. The systemic high-level
expression of CYP1A1 in Arctic beluga suggests that effects of PAHs or PHAHs may be expected
in Arctic populations, as well. The high-level expression of CYP1A1 in the Arctic beluga suggests
that this species is highly sensitive to CYP1A1 induction by aryl hydrocarbon receptor agonists.
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the concentration of non-ortho and mono-
ortho PCBs in blubber—compounds that are
known to induce CYP1A1 through the AHR
(White et al. 1994)—indicating that CYP1A1
is a good biomarker of exposure in beluga. In
this study, we examined cellular location and
relative levels of CYP1A1 expression in multi-
ple organs of beluga whale from the St.
Lawrence estuary and from two locations in
the Arctic (Beaufort Sea and western Hudson
Bay populations). Samples from these popula-
tions might be expected to have different con-
taminant-induced responses, reflecting their
different exposure histories. Beluga from the
St. Lawrence estuary population have high
concentrations of PCBs, chlorinated pesti-
cides (Muir et al. 1996), and metals (mercury,
lead, and selenium) (Wagemann et al. 1990)
in blubber. These animals also show highly
elevated prevalences of overt pathologies
linked to toxicants (Martineau et al. 1988);
thus, we addressed the question of whether
CYP1A1 might be expressed in multiple
organs of beluga from several regions, because
this would indicate whether biochemical
effects in these animals might be occurring
systemically and could indicate the sensitivity
of this species to PHAH toxicity.
Materials and Methods
We obtained tissue samples from multiple
organs of beluga whale from three separate
populations. The public and officials of vari-
ous government agencies reported beluga
whales found dead, stranded on the St.
Lawrence estuary shoreline. The carcasses were
immediately transported by truck to the post-
mortem room of the Faculté de Médecine
Vétérinaire of Université de Montréal, 500 km
to the southwest, where pathologists assisted
by veterinary students examined them upon
arrival. Fourteen beluga were included in this
study from the St. Lawrence estuary. Samples
were additionally collected during subsistence
hunts of the Mackenzie Delta (n = 15) and
Hudson Bay (n = 12) beluga populations. The
ages of the animals from each population
included in this study are shown in Table 1.
Standard body measurements, total body,
organ, and blubber weights, and tooth counts
were determined when possible. Organs sam-
pled included adrenal gland, brain, bladder,
colon, gonad (ovary and testis), heart, kidney,
liver, lung, skin, and thyroid. The time to
necropsy was < 12 hr postmortem for Arctic
animals. For the St. Lawrence beluga, carcasses
were recovered < 3 days after death judging by
the extent of postmortem changes and
accounting for the cold water temperature,
which retards autolysis. Marked autolysis was
seen in the livers of some of the St. Lawrence
beluga. Age was determined in the Hudson
Bay and St. Lawrence beluga by sectioning
teeth longitudinally and counting dentine
growth layers on sections using a binocular
microscope, using the standard of two growth
layers per year (Brodie 1982). We calculated
age for the Mackenzie Delta beluga using
length measurements and established age–
length relationships (Doidge 1990).
The tissues were removed at necropsy, and
small samples were fixed in 10% neutral
buffered formalin, embedded in paraffin, and
sectioned at 5 µm. We assessed CYP1A1
expression by immunohistochemical analysis
with monoclonal antibody (Mab) 1-12-3, as
previously described (Smolowitz et al. 1991).
Mab 1-12-3 recognizes an epitope that in
mammals is specific to CYP1A1 but not to
CYP1A2 (Drahushuk et al. 1998), and use in
Western blot shows a single band in beluga
whale liver microsomes (White et al. 1994).
We calculated a semiquantitative index (0–15)
of CYP1A1 expression determined by
immunohistochemistry by multiplying the
intensity (0–5) and occurrence (0–3) of label
for each cell type in a given organ. A linear
relationship between this index and CYP1A
protein content measured by immunoblot has
been previously shown for expression in liver
and for CYP1A1 induced in cells in culture
(Hahn et al. 1993; Woodin et al. 1997). Serial
sections were stained with the nonspecific
antibody UPC-10 (Sigma-Aldrich Co., St.
Louis, MO, USA) to control for any nonspe-
cific staining. Replicate slides were stained
with hematoxylin and eosin. Although tissue
fixation times were not controlled between the
samples, they were processed into paraffin
blocks within 2 months for all organs except
the adrenal and thyroid gland from the St.
Lawrence beluga. Epitope recognition with
this antibody was equivalent among scup liver
samples held in formalin between 2 weeks and
5 months (Smolowitz R, Stegeman J, unpub-
lished observations), a period encompassing
the times that beluga tissues were in formalin.
Differences in CYP1A1 expression in the
three populations of beluga were determined
using analysis of variance and either the
Tukey-Kramer or Sheffe’s model when there
were unequal or equal numbers of samples,
respectively. Samples were always divided
between site and sex for statistical analyses.
Results and Discussion
Analysis of liver and extrahepatic organs
showed patterns of CYP1A1 expression consis-
tent with a strong induction of CYP1A1, based
on what has been seen in mammalian and non-
mammalian vertebrate models [Tables 1 and 2,
and supplementary material (http://ehp.niehs.
nih.gov/docs/2005/7664/supplement.pdf)].
CYP1A1 expression was seen in vascular
endothelial cells in multiple organs of all indi-
viduals included in this study, including all
lung (n = 33) and skin samples (n = 13) and
nearly all bladder (16 of 18), testes (13 of 17),
and adrenal (12 of 13) samples (Table 3). The
expression of endothelial CYP1A1 in multiple
organs examined from each individual whale
indicates a systemic effect of contaminants in
the Arctic beluga whale. The levels and patterns
of CYP1A1 expression in selected organs are
considered below.
CYP1A1 expression in liver. CYP1A1 was
highly expressed in hepatic parenchyma of
Arctic beluga liver (Table 2). Typically in
mammalian liver, CYP1A1 expression is local-
ized to periportal parenchyma in untreated or
CYP1A1 expression in Arctic beluga
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Table 1. Sample summary.
Published PCB
Site No. Age (years) concentrations (µg/g)a
Mackenzie Delta 12 Male > 9b 4.9
3 Female 4–5b —
Hudson Bay 9 Male 4.5–13 2.7
3 Female 7–17.5 —
St. Lawrence 7 Male Neonate to 26 78.9
7 Female 5–31.5 29.6
—, data not available.
aPCB concentrations were determined in blubber and are based on published data (Muir et al. 1996) and not from samples
included in this study. bBased on age–length relationships (Doidge 1990).
Table 2. CYP1A1 expression in epithelia of selected internal organs of beluga whale determined immuno-
histochemically.a
Liver hepatic Bladder transitional Testis spermatogenic
Site Sex parenchyma epithelium seriesb
Mackenzie Delta Male 11.7 ± 2 (12) 8 ± 1.2 (7) 6.3 ± 1.5 (12)
Female 10 ± 2.8 (2) — —
Hudson Bay Male 12.4 ± 2.1 (7) — 3 ± 1.4 (2)
Female 10 ± 3.5 (3) 12 (1) —
St. Lawrence Male 0.3 ± 0.8 (8)* 6 ± 8.5 (6) 4.5 ± 1.2 (4)
Female 3.3 ± 3.2 (6)* 11.25 ± 2.9 (4) —
—, organ not available.
aCYP1A1 expression levels shown are means ± SD (n). CYP1A1 expression is on a scale of 0–15, based on occurrence and
intensity of staining, as described in “Materials and Methods.” bMay include some Sertoli cells. *Mean is significantly dif-
ferent than other sites at p < 0.05.
slightly induced animals, and panlobular
expression is seen only in animals in which
CYP1A1 is strongly induced (Oinonen and
Lindros 1998). High-level CYP1A1 expression
that is panlobular, as in Figure 1, is fully con-
sistent with CYP1A1 having been strongly
induced in liver of Arctic beluga. Surprisingly,
the levels of CYP1A1 expression in liver from
the highly contaminated St. Lawrence beluga
were significantly lower than those in the
Arctic animals (Table 2), despite the greater
exposure to inducing compounds: liver PCB
concentrations in male beluga average 1,445
ng/g and 132 ng/g in the St. Lawrence and
Arctic, respectively (Metcalfe et al. 1999).
CYP1A1 expression may be suppressed in St.
Lawrence beluga liver, potentially as a result of
high-level contaminant exposure. CYP1A is
suppressed in liver but not in other organs of
fish experimentally exposed to high doses of
non-ortho PCB congeners (e.g., PCB-126)
(Schlezinger and Stegeman 2001). Unlike
PCBs, high levels of PAHs are not known to
suppress CYP1A1 expression.
The time from death to necropsy was
longer for the St. Lawrence beluga than for the
Arctic beluga, and histologic analyses do show
autolysis in these liver samples. Although
CYP1A1 expression in other organs was not
significantly lower in the St. Lawrence beluga
than in Arctic animals, the liver degrades at a
faster rate. It is likely that differences in hepatic
CYP1A1 expression simply reflect degradation
and the difference between time of death and
fixation for samples collected from subsistence
hunts and strandings. Unfortunately, it is
impossible to collect from these sites under
identical conditions. There are no subsistence
hunts of the St. Lawrence beluga population,
and locating stranded animals in the Arctic is
not feasible. Yet the pattern and levels of
CYP1A1 expression in Arctic animals indicate
a substantial induction in those beluga.
CYP1A1 expression in lung. As indicated
above, endothelial CYP1A1 levels (Table 3,
Figure 2A,C,D) were high in lung. CYP1A1
expression was seen also in chondrocytes and
bronchiolar epithelium but was not seen in
type 1 or type 2 pneumocytes [see supplemen-
tary material (http://ehp.niehs.nih.gov/
docs/2005/7664/supplement.pdf)]. The pre-
dominant environmental exposure route for
CYP1A1 inducers is dietary, but a recent
study in mice suggests that PCB uptake can be
greater via inhalation than from diet (Casey
et al. 1999). Thus, consideration of nondietary
exposures such as inhalation may be warranted
in regions where PAH and/or PCB exposure
levels are likely to be high. Hormonal, histo-
pathologic, and behavioral changes were seen in
mice exposed to 0.9 µg/m3 Aroclor 1242 in the
air (Casey et al. 1999), a concentration that is
approximately 10,000-fold higher than Arctic
atmospheric PCB concentrations (MacDonald
et al. 2000). Atmospheric sources of PCBs in
the Arctic could result in an estimated lung
exposure of 1.3–67 ng/day in Arctic beluga
(Table 4). Likewise, an inhaled PAH exposure
could be expected to range from 5.6 to
363 ng/day in Arctic beluga (Table 4), although
this exposure would be dominated by lower-
molecular-weight PAHs such as fluorene and
phenanthrene (MacDonald et al. 2000), which
do not typically induce CYP1A (Bols et al.
1999). Given that, and considering that type 1
pneumocytes (the pulmonary cell type primar-
ily involved in gas exchange in the lung) did
not express CYP1A1 in beluga, it is more plau-
sible to conclude that CYP1A1 induction in
lung was solely the result of dietary exposure
and that the contribution of inhaled contami-
nants was marginal.
CYP1A1 expression in bladder. In bladder,
CYP1A1 was highly expressed in both endothe-
lium (Table 3, Figure 2B) and transitional
epithelium forming the bladder mucosa
(Table 2, Figure 3). CYP1A1 in transitional
epithelium was most highly expressed in
umbrella cells, the cells in direct contact with
urine. A transitional cell carcinoma of the blad-
der has been found in a beluga from the highly
contaminated St. Lawrence estuary (Martineau
et al. 1985). In humans, CYP1A is involved in
the activation of a variety of potential bladder
carcinogens (Gonzalez and Gelboin 1994), is
expressed in primary transitional cell tumors of
the urinary bladder, and has been correlated
with tumor grade (G1–G3) (Murray et al.
1995). CYP1A1 could be involved in the devel-
opment of bladder tumor in the St. Lawrence
beluga population.
The expression of CYP1A1 in bladder
was as high in the Arctic beluga as in the St.
Lawrence beluga. Considering that, in the
transitional epithelium, the most highly
induced cells were in direct contact with urine
(Figure 3), the induction of CYP1A1 in blad-
der presumably was caused by contaminants
excreted into the urine. Potential CYP1A1
inducers in urine include both PCBs and
PAHs. PAHs are eliminated more rapidly and
therefore accumulate to a much lower degree
than do PCBs, yet higher levels of exposure
would still result in significant CYP1A1
induction. In the St. Lawrence estuary, PAH
exposures are higher and likely more impor-
tant for CYP1A1 induction than in the
Arctic: Sediment-associated PAHs are
Wilson et al.
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Table 3. Endothelial CYP1A1 expression in selected internal organs of beluga whale determined immuno-
histochemically.a
Site Sex Brain Bladder Gonad Kidney Liver Lung
Mackenzie Delta M 1.6 ± 1.4 (12) 8 ± 1.2 (7) 5 ± 2.6 (12) 6.5 ± 2.1* (12) 3.75 ± 3.1 (12) 9.1 ± 2.1 (12)
F 1.5 ± 2.1 (2) — 2.25 ± 3.2 (2) 9 ± 1.4* (2) 2 ± 2.8 (2) 8 ± 2.8 (2)
Hudson Bay M 1.7 ± 2.6 (6) — 1 ± 1.4 (2) 1.8 ± 2.3 (9) 2.8 ± 4.1 (7) 6.7 ± 3.7 (9)
F 0 ± 0 (2) 0 (1) — 0 ± 0 (3) 0.7 ± 1.2 (3) 5.5 ± 1.8 (3)
St. Lawrence M 2.3 ± 3.7 (8) 7.6 ± 6.1 (6) 2.7 ± 4.6 (4) 0 ± 0 (7) 0 ± 0 (8) 7 ± 1.4 (4)
F 3 ± 3.0 (5) 13.1 ± 3.8 (4) 1.25 ± 1.5 (4) 2.2 ± 2.8 (7) 1.6 ± 1.9 (6) 6.3 ± 3.5 (5)
Abbreviations: —, organ not available; F, female; M, male.
aCYP1A1 expression levels shown are means ± SD (n). CYP1A1 expression is on a scale of 0–15, based on occurrence and
intensity of staining, as described in “Materials and Methods.” *Mean is significantly different than other sites at p < 0.05.
Figure 1. CYP1A1 expression in liver from beluga whale. CYP1A1 is labeled pink to dark red; arrows indicate cells with labeling and the identical cell type without
labeling. (A) CYP1A1 expression in hepatic parenchyma from an Arctic beluga. (B) Serial section from Arctic beluga shown in (A) stained using the nonspecific
antibody UPC-10. (C) CYP1A1 expression in hepatic parenchyma from a St. Lawrence beluga. Magnification, 400×.
500–4,500 ng/g (Martel et al. 1986) and
400–980 ng/g (MacDonald et al. 2000) in
the St. Lawrence and Arctic, respectively.
The relative contribution of PCBs and PAHs
to urinary contaminants is unknown in the
St. Lawrence beluga. In the Arctic, where
contaminants are atmospherically derived,
atmospheric PAHs are dominated by those
that do not induce CYP1A1 (MacDonald
et al. 2000); thus, PAH contributions to
CYP1A1 induction may be minimal in Arctic
beluga whales.
PCBs that are AHR agonists are highly
correlated to CYP1A1 levels in liver of Arctic
beluga (White et al. 1994), indicating that
induction of CYP1A1 in bladder of Arctic bel-
uga is likely to be related to PCB exposure. In
mice exposed to PCBs in the diet, only 5% of
oral dose appeared in urine, mainly as conju-
gates (Wehler et al. 1989). We calculated a
total body burden based on PCB concentra-
tions in the blubber, blubber weight, and total
body weight (Table 5). Given this total body
dose, we can estimate an upper limit on the
maximal oral dose in Arctic beluga. The uri-
nary PCB concentrations would be very small
in the Arctic beluga, presumably much less
than 0.05–0.1 mg/kg (5% of the upper limit
on the maximal oral dose), because we would
expect most urinary PCBs to be conjugated
and not able to induce CYP1A1. These results
suggest that the doses required for CYP1A1
induction in bladder are low and indicate that
beluga are very sensitive in their responses to
PHAH contaminants. Determining urinary
concentrations of PAHs and PCBs would be
important to confirm that such compounds
are present in this organ and what concen-
trations are responsible for such high-level
CYP1A1 expression.
CYP1A1 expression in testis. Moderate
levels of CYP1A1 expression were seen in the
spermatogenic series in the testis (Table 1).
Although this may have included some Sertoli
cells, CYP1A1 expression appeared primarily in
spermatogonia and spermatocytes. In studies
with several other mammals, testicular microso-
mal preparations have shown very low or no
CYP1A activity (Machala et al. 1998; Revel
et al. 2001; Roman et al. 1998). Testicular
CYP1A activity was not induced in rats (Roman
et al. 1998), bulls (Machala et al. 1998), or mice
(Revel et al. 2001) exposed to a variety of induc-
ers, although the AHR and dimerization partner
ARNT (aryl hydrocarbon receptor nuclear
translocator), which are required for CYP1A
induction, are present in testis (Roman et al.
1998). Immunohistochemical analyses of
mouse testes showed CYP1A1 in interstitial
cells only, and this was reportedly not induced
by benzo[a]pyrene (Revel et al. 2001). CYP1A1
expression in the spermatogenic series is an
unusual finding in a mammalian species.
Considering that CYP1A1 is involved in the
activation of procarcinogens and generation of
reactive oxygen species, high-level CYP1A1
CYP1A1 expression in Arctic beluga
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Figure 2. CYP1A1 expression in lung and bladder endothelium from beluga whale. CYP1A1 is labeled pink to dark red; arrows indicate cells with labeling and the
identical cell type without labeling. (A) CYP1A1 expression in lung endothelium from an Arctic beluga. (B) CYP1A1 expression in bladder endothelium from an
arteriole from an Arctic beluga. (C) CYP1A1 expression in lung endothelium from an Arctic beluga. (D) Serial section from Arctic beluga shown in (C) was labeled
using the nonspecific antibody UPC-10. Magnification: A, C, D, 400×; B, 200×.
Table 4. PCB and PAH dose to lungs of Arctic
beluga whale via inhalation.














aWartzok (2002). bCockcroft and Ross (1990). cTidal volume
(L) × respiration rate (breaths/min) × 1,440 min/day.
dMacDonald et al. (2000). eAir concentration (pg/m) × volume
inspired (L/day) × 0.001 m3/L.
Figure 3. CYP1A1 expression in transitional epithelium from the bladder of Arctic beluga whale. CYP1A1 is
labeled pink to dark red; arrows indicate cells with labeling and the identical cell type without labeling.
(A) CYP1A1 expression in the transitional epithelium of bladder; labeling is most intense in the umbrella
cells. (B) Serial section from beluga shown in (A) labeled using the nonspecific antibody UPC-10.
Magnification, 400×.
expression in the spermatogenic series could
be significant for sperm function and gamete
development.
Implications of CYP1A1 induction in bel-
uga. The high levels of CYP1A1 expression in
the beluga whale from both the Arctic and the
St. Lawrence estuary are consistent with high
sensitivity of this species to CYP1A inducers.
Interestingly, except for the liver, the level of
expression was not markedly different between
animals from the St. Lawrence estuary and
those from the Arctic, despite significant
differences in contaminant exposure and
apparent tumor prevalence. No tumors were
found in 50 Arctic beluga examined, whereas
21 tumors were found in 100 St. Lawrence
beluga, resulting in an annual cancer rate of
163 per 100,000 animals calculated for the St.
Lawrence estuary beluga (Martineau et al.
2002). However, the necropsies on the Arctic
beluga were not as detailed as necropsies on
the St. Lawrence animals, and the Arctic ani-
mals examined were much younger. Detailed
necropsies will need to be performed on older
Arctic animals to determine the prevalence of
tumors in Arctic populations of beluga.
Liver CYP1A1 expression was previously
shown to be highly correlated to mono-ortho
and non-ortho PCBs, ligands for the AHR, in
the blubber of Arctic beluga whale (White
et al. 1994). The high levels and cellular pat-
terns of CYP1A1 expression are similar to
those seen in animal models exposed to high
levels of inducers; other mammals do not show
this broad pattern of induction unless exposed
to high concentrations of contaminants. Thus,
even lower doses of contaminants, like those
seen in the Arctic animals, appear able to
highly induce CYP1A1 in beluga. Beluga
whales express levels of CYP1A1 in various
organs that are similar to or greater than levels
of expression in organs of other cetaceans for
which such data are available (Wilson 2003),
despite having lower levels of potential induc-
ers in their tissues. These data support the idea
that beluga are a more sensitive species, at least
compared with other cetaceans. The sensitivity
of beluga to CYP1A1 inducers is reflected also
in the beluga AHR. The beluga AHR has been
cloned, expressed, and shown to bind 2,3,7,8-
tetrachlorodibenzo-p-dioxin (a prototypical
inducer) with a similar binding affinity to that
of the C57 strain mouse (Jensen and Hahn
2001). This strain of mouse is highly sensitive
to PHAH toxicity (Shen et al. 1991), and the
AHR properties suggest that beluga may be
similarly sensitive to these contaminants. In the
St. Lawrence estuary, only beluga, and not
other resident cetacean species, have been
found with tumors (De Guise et al. 1994),
indicating that beluga may also be particularly
susceptible to chemical carcinogenesis. The fact
that beluga show a systemic response to
CYP1A1 inducers, even at lower doses, indi-
cates that other toxic effects elicited by AHR
agonists may be expected, even in populations
from the relatively uncontaminated Arctic.
Conclusions
Although Arctic cetaceans have contaminant
concentrations that are among the lowest
reported, these exposures still could be biologi-
cally significant. Despite such low exposures,
Arctic beluga have a pattern and extent of
CYP1A1 expression that is similar to those
seen in animal models that are maximally
induced. These data, supported by in vitro
studies of the beluga AHR (Jensen and Hahn
2001), and the presence of tumors only in bel-
uga but not other cetaceans resident in the St.
Lawrence estuary (De Guise et al. 1994), sug-
gest that beluga are highly sensitive to CYP1A1
inducer substrates. In the St. Lawrence estuary,
CYP1A1 could be involved in the develop-
ment of neoplastic lesions seen in this beluga
population (Martineau et al. 1994). Because
beluga have a systemic response to PHAH con-
taminants at low doses, toxic effects may be
expected in Arctic populations.
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